Dr. James A. Wheeler, MD

Dr. Wheeler practices at Goshen Hospital in Goshen, Indiana, part of Parkview Health System.

Dr. Wheeler's NPI, 1790745412, was assigned on March 25, 2006. Dr. Wheeler graduated from University of Kansas School of Med (KC/Wich/Sal) in 1989. Dr. Wheeler holds Indiana license 01061266A.

Dr. Wheeler's primary practice is Goshen Hospital, at 200 High Park Ave, Goshen, IN 46526 in Elkhart County. The practice phone is (574) 364-1000.

Dr. Wheeler's primary practice is Goshen Hospital in Goshen, Indiana, part of Parkview Health System. The medical group on file is Goshen Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wheeler practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Wheeler's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Wheeler is licensed in Indiana.

CMS data shows 43 Medicare services from Dr. Wheeler across 1 procedure code in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $1,953 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Dr. Wheeler in 2024. The largest group is 75 to 84, with 19 patients. 75% of them have high cholesterol, and 73% have cancer. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wheeler's median patient age at 74, with 30% women.

In 2023, Dr. Wheeler wrote 33 Medicare Part D claims. They cover 3 drugs, with $547 in total drug cost. In 2022, CMS named 80 claims across 6 drugs.

Dr. Wheeler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Wheeler, published from 2012 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents and Breast Neoplasms. Dr. Wheeler has published most often in Pract Radiat Oncol. Dr. Wheeler's most frequent co-authors are Carryn M. Anderson, MD, Dukagjin M. Blakaj, MD and Marcelo Raul Bonomi, MD.

Dmand AI links Dr. Wheeler to 6 clinical trials, 2 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Stomatitis, COVID-19 and Oral Ulcer. Galera Therapeutics, Inc. sponsors the most, 2.

CMS Open Payments shows 39 general payments to Dr. Wheeler from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Varian Medical Systems, Inc. paid the most, $1,334.

Dr. Wheeler graduated from University of Kansas School of Med (KC/Wich/Sal) in 1989.